15 October 2025
Three Malaghan researchers have been awarded research and travel grants in the latest round of Research for Life funding.

From left: Dr Nathaniel Dasyam, Brigitta Mester, Jessica Cotterel
Dr Nathaniel Dasyam, postdoctoral research fellow in the Weinkove Lab received a research grant to fund a project investigating the conditional expression of support molecules for chimeric antigen receptor T-cell therapies.
“CAR T-cell treatment works by taking a patient’s own immune cells, reprogramming them to recognise cancer cells, and returning them to the body to attack the disease,” says Dr Dasyam. “It can be life-changing, but some tumours push back or send “stop signals” that weaken the therapy.
“This project aims to overcome these stop signals, the tuning of which must be highly controlled to avoid toxicities. I will test new targeted CAR designs in the lab to help CAR T-cells keep working for longer and stay effective in tough tumour environments, with the goal of improving benefits while keeping treatment safe.
Brigitta Mester, Process Development Manager in the Weinkove Lab, received a travel grant to attend the International Society of Cell and Gene Therapy (ISCT) annual conference in Dublin, Ireland, while Jessica Cotterel, PhD Student in the Connor Lab, was awarded funding to attend the Keystone Symposia on B and T Cell Collaboration in Lymphoid and Non-lymphoid Microenvironments in Colorado, USA.
Related articles

Malaghan scientists awarded Research for Life grants
15 October 2025

Malaghan alumni series: Professor Paige Lacy
14 October 2025

New funding supports cutting-edge research into immune cell metabolism
13 October 2025

Study explores wearable devices to improve blood cancer patient monitoring
8 October 2025

The Detail: The viral drift of misinformation
29 September 2025

Blood, sweat and cells: The making of New Zealand’s first CAR T-cell trial
24 September 2025